LLS compounds for treatment of cancer
US10844052B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 2017 |
| Grant date | Nov 24, 2020 |
| Priority date | — |
| Expiry date | Apr 4, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides benzamidazole compounds and methods of using the compounds as galectin-1 inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.